Abstract
Tumors in the central nervous system (CNS) arise from different cell components of the CNS and are classified as shown in Table 1 (see also ref. 1). It is well known that the tumors in the CNS, especially glioma, produce various cytokines including interleukins (ILs), tumor necrosis factor-α (TNF-α), and colony-stimulating factors [recently reviewed by van Meir (2)]. Although the significance of cytokine production by the tumors may not be biologically clear, these cytokines could affect the biology of the tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kleihues, P. C. Burger, and B. W. Scheithauer. 1993. The new WHO classification of brain tumours. Brain Pathol. 3: 255–268.
van Meir, E. G. 1995. Cytokines and tumors of central nervous system. Glia 15: 264–288.
Evans, R. 1972. Macrophages in syngeneic tumors. Transplantation 14: 468–473.
Evans, R., and S. Haskill. 1983. Activities of macrophages within and peripheral to the tumor mass, in The Reticuloendothelial System ( Herberman, R. B., ed.), Plenum, New York, pp. 155–176.
Kuratsu, J., E. J. Leonard, and T. Yoshimura. 1989. Production and characterization of human glioma cell-derived monocyte chemotactic factor. J. Natl. Cancer Inst. 81: 347–351.
Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, J. Kuratsu, and E. J. Leonard. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169: 1449–1459.
Yoshimura, T., N. Yuhki, S. K. Moore, E. Appella, M. I. Lerman, and E. J. Leonard. 1989. Human monocyte chemoattractant protein-1 (MCP-1): full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244: 487–493.
Yoshimura, T., and A. Ueda. 1996. Structure, function, and mechanism of action of monocyte chemoattractant protein-1, in Human Cytokines: Handbook for Basic and Clinical Research, Vol. II ( Aggarwal, B. B., and J. U. Gutterman, eds.), Blackwell, Cambridge, MA, pp. 198–221.
Rollins, B. J. 1991. JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine. Cancer Cells 3: 517–524.
Kuratsu, J., and Y. Ushio. 1996. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan. J. Neurosurg. 84: 946–950.
Phillips, J. P., 0. Eremin, and J. R. Anderson. 1982. Lymphoreticular cells in human brain tumors and in normal brain. Br. J. Cancer 45: 61–69.
von Hanwehr, R. I., F. Hofman, C. Taylor, and M. L. J. Apuzzo. 1984. Mononuclear lymphoid population infiltrating the microenvironment of primary CNS tumors: characterization of cell subsets with monoclonal antibodies. J. Neurosurg. 60: 1138–1147.
Wood, G. W., and R. A. Moranz. 1979. Immunological evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J. Natl. Cancer Inst. 62: 485–491.
Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, and E. J. Leonard. 1989. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 142: 1956–1962.
Robinson, E. A., T. Yoshimura, E. J. Leonard, S. Tanaka, P. R. Griffin, J. Shabanowitz, D. F. Hunt, and E. Appella. 1989. Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc. Natl. Acad. Sci. USA 86: 1850–1854.
Rutledge, B. J., H. Rayburn, R. Rosenberg, R. J. North, R. P. Gladue, C. L. Cordless, and B. J. Rollins. 1995. High level of monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol. 155: 4838–4843.
Fuentes, M. E., S. K. Durham, M. R. Swerdel, A. C. Lewin, D. S. Barton, J. R. Megill, R. Bravo, and S. A. Lira. 1995. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J. Immunol. 155: 5769–5776.
Nakamura, K., I. R. Williams, and T. S. Kupper. 1996. Keratinocyte-derived monocyte chemoattractant protein-1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J. Invest. Dermatol. 105: 635–643.
Gunn, M. D., N. A. Nelken, X. Liao, and L. T. Williams. 1997. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J. Immunol. 158: 376–383.
Yoshimura, T. 1993. cDNA cloning of guinea pig monocyte chemoattractant protein-1 and expression of the recombinant protein. J. Immunol. 150: 5025–5032.
Yamashiro, S., M. Takeya, J. Kuratsu, Y. Ushio, K. Takahashi, and T. Yoshimura. 1998. Intradermal injection of monocyte chemoattractant protein-1 induces emigration and differentiation of blood monocytes in rat skin. Int. Arch. Allergy Immunol. 115: 15–23.
Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94: 12,053–12, 058.
Carr, M. W., S. J. Roth, E. Luther, S. S. Ross, and T. A. Springer. 1994. Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91: 3652–3656.
Rand, M. L., J. S. Warren, M. K. Mansour, W. Newman, and D. J. Ringler. 1996. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am. J. Pathol. 148: 855–864.
Kasahara, T., N. Mukaida, K. Yamada, H. Yagisawa, T. Akahoshi, and K. Matsushima. 1991. IL-1 and TNF-a induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74: 60–67.
Takeshima, H., J. Kuratsu, M. Takeya, T. Yoshimura, and Y. Ushio. 1994. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J. Neurosurg. 80: 1056–1062.
Desbaillets, I., M. Tada, N. de Trobolet, A.-C. Diserens, M.-F. Hamou, and E. G. van Meir. 1994. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int. J. Cancer 58: 240–247.
Yoshizato, K., J. Kuratsu, H. Takeshima, T. Nishi, T. Yoshimura, and Y. Ushio. 1996. Tumor necrosis factor-a-induced macrophage infiltration in gliomas is mediated by the production of monocyte chemoattractant protein-1. Int. J. Oncol. 8: 493–497.
Ueda, A., K. Okuda, S. Ohno, A. Shirai, T. Igarashi, K. Matsunaga, J. Fukushima, S. Kawamoto, Y. Ishigatsubo, and T. Okubo. 1994. NF-KB and Sp1 regulate transcription of human monocyte chemoattractant protein-1 gene. J. Immunol. 153: 2052–2063.
Ueda, A., Y. Ishigatsubo, T. Okubo, and T. Yoshimura. 1997. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene: cooperation of two NF-kB sites and NF-kB/rel subunit specificity. J. Biol. Chem. 272: 31,092–31, 099.
Kuratsu, J., K. Yoshizato, T. Yoshimura, E. J. Leonard, H. Takeshima, and Y. Ushio. 1993. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluids and cyst fluids from patients with malignant glioma. J. Natl. Cancer Inst. 85: 1836–1839.
Morantz, R. A., G. W. Wood, M. Foster, M. Clark, and K. Gollahon. 1979. Macrophages in experimental and human brain tumors. J. Neurosurg. 50: 305–311.
Sato, K., J. Kuratsu, H. Takeshima, T. Yoshimura, and Y. Ushio. 1995. Expression of monocyte chemoattractant protein-1 in meningioma. J. Neurosurg. 82: 874–878.
Cochran, B. H., A. C. Reffel, and C. D. Stiles. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33: 939–947.
Todo, T., E. Adams, and R. Fahlbusch. 1993 Inhibitory effect of trapidil on human meningioma cell population via interruption of autocrine growth stimulation. J. Neurosurg. 78: 463–469.
Bruce, J. N., G. R. Criscuolo, M. J. Merrill, R. R. Moquin, J. B. Blacklock, and E. H. Oldfield. 1987. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J. Neurosurg. 67: 880–884.
Shinonaga, M., C. C. Chan, N. Suzuki, M. Sato, and T. Kawabara. 1988. Immunohistological evaluation of macrophage infiltrates in brain tumors. J. Neurosurg. 68: 259–265.
Morahan, P., A. Volkman, M. Melnicoff, and W. Dempsey. 1988. Macrophage heterogeneity, in Macrophages and Cancer (Hepper, G. H., and A. M. Fulton, eds.), CRC, Boca Raton, FL, pp. 2–25.
Dijkstra, C., E. Döpp, P. Joling, and G. Kraal. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies, ED1, ED2, and ED3. Immunology 54: 580–598.
Polman, C. H., C. D. Dijkstra, T. Sminia, and J. C. Koetsier. 1986 Immunohistological analysis of macrophages in the central nervous system of Lewis rats with acute experimental allergic encephalomyelitis. J. Neuroimmunol. 11: 215–222.
Verschure, P. J., J. F. van Noorden, and C. D. Dijkstra. 1989. Macrophages and dendritic cells during the early stages of antigen-induced arthritis in rats: immunohistochemical analysis of cryostat sections of the whole knee joint. Scand. J. Immunol. 29: 371–381.
Dijkstra, C. D., E. A. Döpp, I. M. C. Vogels, and C. J. F. van Noorden. 1987. Macrophages and dendritic cells during antigen-induced arthritis: an immunohistochemical study using cryostat sections of the whole knee joint of rat. Scand. J. Immunol. 26: 513–523.
Miyamura, S., M. Naito, M. Takeya, H. Okumura, and K. Takahashi. 1988. Analysis of rat peritoneal macrophages with combined ultrastructural peroxidase cytochemistry and immunoelectron microscopy using anti-rat macrophage monoclonal antibodies. J. Clin. Electron Microsc. 21: 545–546.
Takeya, M., L. Hsiao, and K. Takahashi. 1987. A new monoclonal antibody, TRPM-3, binds specifically to certain rat macrophage populations: immunohistochemical and immunelectron microscopic analysis. J. Leukoc. Biol. 41: 187–195.
Yamashiro, S., M. Takeya, T. Nishi, J. Kuratsu, T. Yoshimura, Y. Ushio, and K. Takahashi. 1994. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am. J. Pathol. 145: 913–921.
Zhang, L., T. Yoshimura, and D. T. Graves. 1997. Antibody to Mac-1 or MCP-1 inhibits monocyte recruitment and promotes tumor growth. J. Immunol. 158: 4855–4861.
Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169: 1485–1490.
Nishi, T., K. Yoshizato, S. Yamashiro, H. Takeshima, K. Sato, K. Hamada, I. Kitamura, T. Yoshimura, H. Saya, J. Kuratsu, and Y. Ushio. 1996. High-efficiency in vivo gene transfer using intra-arterial plasmid DNA injection following in vivo electroporation. Cancer Res. 56: 1050–1055.
Manome, Y., P. Y. Wen, A. Hershowitz, T. Tanaka, B. J. Rollins, D. W. Kufe, and H. A. Fine. 1995. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41: 227–235.
Tada, M., Y. Sawamura, S. Sakuma, K. Suzuki, H. Ohta, T. Aida, and H. Abe. 1993. Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor a for the treatment of malignant gliomas. Cancer Immunol. Immunother. 36: 251–259.
Mukaida, N., M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima. 1994. Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-KB is target for glucocorticoid-mediated interleukin 8 gene expression. J. Biol. Chem. 269: 13,289–13, 295.
Mukaida, N., S. Okamoto, Y. Ishikawa, and K. Matsushima. 1994. Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol. 56: 554–558.
Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IKBa in mediation of immunosuppression by glucocorticoids. Science 270: 283–286.
Auphan, N., J. A. DiDonato, C. Rosette, A. Helberg, and M. Karin. 1995 Immunosuppression by glucocorticoids: inhibition of NF-KB activity through induction of IKB synthesis. Science 270: 286–289.
van Meir, E., M. Ceska, F. Effenberger, A. Walz, E. Grouzmann, I. Desbaillets, K. Frei, A. Fontana, and N. de Tribolet. 1992. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res. 52: 4297–4305.
Tada, M., K. Suzuki, Y. Yamakawa, Y. Sawamura, S. Sakuma, H. Abe, E. van Meir, and N. de Tribolet. 1993. Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-8 (77)). J. Neurooncol. 16: 25–34.
Yoshimura, T., E. A. Robinson, E. Appella, K. Matsushima, S. D. Showalter, A. Skeel, and E. J. Leonard. 1989. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino terminal sequence. Mol. Immunol. 26: 87–93.
Rollins, B. J., and M. Sunday. 1991. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell Biol. 11: 3125–3131.
Walter, S., B. Bottazzi, D. Govoni, F. Colotta, and A. Mantovani. 1991. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 49: 431–435.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yoshimura, T., Kuratsu, Ji. (1999). Chemokines and Central Nervous System Malignancies. In: Rollins, B.J. (eds) Chemokines and Cancer. Contemporary Cancer Research. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-701-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-701-7_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-4760-7
Online ISBN: 978-1-59259-701-7
eBook Packages: Springer Book Archive